West Pharmaceutical Services
West Pharmaceutical Services, Inc. (NYSE: WST) designs and manufactures containment and delivery systems for injectable drugs and healthcare products, serving biologic, generic, pharmaceutical, diagnostic and medical device companies. Its two reportable segments are Proprietary Products, which supplies primary… From the company’s description.
In fiscal 2025, West Pharmaceutical Services reported revenue of $3.07B, up 6.3% from fiscal 2024, and net income of $493.70M. Its operating margin was 19.0%, and operations generated $754.80M in cash. Over the twelve months to Jun 30, 2026, revenue was $3.33B.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What West Pharmaceutical Services does
In the company’s own words
West Pharmaceutical Services, Inc. (NYSE: WST) designs and manufactures containment and delivery systems for injectable drugs and healthcare products, serving biologic, generic, pharmaceutical, diagnostic and medical device companies. Its two reportable segments are Proprietary Products, which supplies primary packaging components, containment solutions, drug delivery devices, integrated systems and analytical lab services, and Contract-Manufactured Products, which designs, manufactures and assembles complex devices and components for pharmaceutical, diagnostic and medical device customers. Proprietary Products include stoppers, seals, syringe and cartridge components, vials, plungers and self-injection devices; contract manufacturing uses technologies such as multi-component molding and automated assembly. West also provides engineering, regulatory and technical support. Outside the United States accounted for 56.7% of consolidated net sales in 2025, and the company employed approximately 10,800 people worldwide at year-end. Its website is www.westpharma.com.
Company details
- Sector
- Health Care
- Industry (SIC)
- Surgical & Medical Instruments
- Headquarters
- EXTON, PA
- Fiscal year end
- December
- CIK
- 105770
- SIC
- 3841
Financial performance, year by year
Fiscal 2013–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns West Pharmaceutical Services — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Superinvestors in West Pharmaceutical Services · what they did last quarter
Share of each manager’s reported 13F portfolio. Change is in shares held, since the previous quarter.
Largest fund holders · West Pharmaceutical Services’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do West Pharmaceutical Services and its peers compare on margins and cash generation over ten years?”
- “Where did five years of West Pharmaceutical Services's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in West Pharmaceutical Services's last four quarterly filings that the numbers alone won't show?”